| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |